Experience

Princeton Capital Advisors

• United States
• Business Consulting and Services
• 1 - 100 Employee

• Senior Advisor

  • Okt. 2020 - –Heute



Spirify Pharma, Inc.

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Business Officer

  • Okt. 2021 - –Heute

  As CBO at Spirify Pharma, Inc. I am responsible for business and corporate development, licensing, and strategic planning. As CBO at Spirify Pharma, Inc. I am responsible for business and corporate development, licensing, and strategic planning.



Enalare Therapeutics Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Advisory Board Member

  • Dez. 2020 - –Heute

  Proudly supporting the Executive Leadership team at Enalare Therapeutics Proudly supporting the Executive Leadership team at Enalare Therapeutics



AK Pharma Consulting

• Germany
• Business Consulting and Services

• Consultant in Pharmaceutical and Biotech

  • Apr. 2020 - –Heute



Aquestive Therapeutics

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Head of Search and Evaluation

  • Nov. 2018 - März 2020

  Responsible for all aspects of the Aquestive's opportunity identification and evaluation process for selecting molecules, products, and technologies to acquire, develop, and/or license in order to enrich the company's pipeline. Responsible for all aspects of the Aquestive's opportunity identification and evaluation process for selecting molecules, products, and technologies to acquire, develop, and/or license in order to enrich the company's pipeline.



AK Pharma Consulting

• Germany
• Business Consulting and Services

• Proprietor Consultant

  • Nov. 2017 - Okt. 2018

  Consulting with start-ups, biotech, and pharmaceutical companies. Provided strategic consultancy and assistance in R&D, business and portfolio development. Consulting with start-ups, biotech, and pharmaceutical companies. Provided strategic consultancy and assistance in R&D, business and portfolio development.



Grünenthal Group

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• VP, Commercial Lead INTAC® and Lead External Search & Scientific Evaluation North America

  • Jan. 2017 - Okt. 2017

  As Commercial Lead INTAC®:Define and optimize Marketing and Brand Communication strategy around company’s abuse deterrent technology in North American markets. Evaluate market for new product opportunities and derive value proposition and marketing strategies. As Lead External Search & Scientific Evaluation:Responsible for asset search/identification and scientific/regulatory assessment of potential in-licensing opportunities for company’s North American business.Leadership responsibility for cross-functional team and coordination of scientific and commercial assessments within valuation team.

• VP Product Development, Technical and Government Affairs

  • Apr. 2013 - Dez. 2016

  Responsible for aligning Strategic Marketing, Business Development, R&D/Patent Strategy, and Public/Government Relations activities to drive market access of abuse deterrent technology in North American markets. Responsible for new product/partner identification around INTAC® technology and initiation of BD&L process.

• Head Global TRF Business

  • Juli 2011 - März 2013

  Cross-functional leadership responsibility for international matrix team (R&D, IP, CI, Regulatory Affairs, Strategic Marketing, Commercial, BD&L) to grow and expand abuse deterrent technologies (ADF) as market opportunity (US, globally) for improved opioid pain therapy. Consolidated company’s proprietary technology and IP portfolio for ADF and focused development efforts on new and most promising product and partnering opportunities.

• Chief Executive Officer Grünenthal USA, Inc.

  • Juli 2010 - Juni 2011

  General management responsibility for US affiliate of Grünenthal, including legal, HR, finance, and Clinical Operations, reporting into Corporate Executive Board.

• Chief Scientific Officer Grünenthal USA, Inc.

  • Mai 2009 - Juli 2010

  Describe your position

• Chief Operations Officer Grünenthal USA, Inc.

  • Mai 2009 - Juli 2010

  Describe your position



Grünenthal Pharma GmbH & Co. KG

• Head Department of Pharmacokinetics

  • Apr. 2001 - Apr. 2009

  Accountable for all pharmacokinetic activities within projects from early ADME, candidate selection, first-into-man to clinical Phase-II/III. Coordination of capacity resources (12 PhDs, 41 staff) and departmental budget. Coordination of due diligence activities with BD&L. Due Diligence support for BD&L group.

• Scientist Department of Pharmacokinetics

  • Sept. 1999 - März 2001

  Responsible for development and implementation of cross-functional analysis tools in Drug Discovery to support rationale candidate selection.